Jamie Murphy
Comptroller/Controller/Auditor bei SIGILON THERAPEUTICS, INC.
Profil
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Aktive Positionen von Jamie Murphy
| Unternehmen | Position | Beginn |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Ehemalige bekannte Positionen von Jamie Murphy
| Unternehmen | Position | Ende |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Jamie Murphy
| Wake Forest University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
